What precautions should be taken when injecting dermal fillers, such as Juvederm (hyaluronic acid) or Restylane (hyaluronic acid), near the mental artery to avoid vascular complications?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Mental Artery and Dermal Fillers: Critical Safety Protocol

Immediate Safety Recommendations

When injecting dermal fillers near the mental artery, use strict intradermal placement with 30-gauge needles at shallow angles, aspirate before every injection, inject small aliquots slowly while observing for blanching, and maintain immediate access to high-dose hyaluronidase for emergency treatment of vascular occlusion. 1, 2

Pre-Injection Safety Protocol

Anatomical Considerations

  • The mental artery emerges from the mental foramen and supplies the chin and lower lip region, residing in the hypodermis well below the dermal layer where safe filler injections should occur 1
  • Target only the dermis layer using intradermal technique to avoid the deeper hypodermis where the mental artery and its branches reside 1

Mandatory Technical Precautions

  • Use 30-gauge, 4mm length needles inserted at shallow angles with bevel facing upward to ensure intradermal placement 1
  • Aspirate the needle prior to each injection to detect intravascular placement before filler administration 3, 1
  • Inject small incremental volumes (0.1 mL or less per injection site) rather than large boluses to minimize vascular compression and allow early detection of complications 1, 2
  • Create visible papules or wheals with blanching during injection to confirm proper intradermal placement and prove you are NOT in the hypodermis where major vessels exist 1

Advanced Safety Measures

  • While ultrasonographic guidance and intravascular markers have been suggested as additional precautions to avoid introducing filler directly into vessels, these methods may be considered but are not practical for everyday use by most practitioners 3
  • The formation of a papule with blanching during injection confirms intradermal placement and avoids placing product into deep underlying vasculature 1

Recognition of Vascular Occlusion

Immediate Clinical Signs (Within Minutes to Hours)

  • Skin blanching is the earliest and most critical warning sign of arterial occlusion 2
  • Livedo reticularis pattern on the skin 2
  • Slow capillary refill time 2
  • Dusky blue-red discoloration of affected tissue 2
  • Severe pain disproportionate to the procedure, particularly in the mandible or muscles during swallowing, indicates possible ischemia of structures supplied by the mental artery 4

Delayed Signs (Days Later)

  • Blister formation followed by tissue slough if untreated 2
  • Progressive skin necrosis in the vascular territory of the mental artery 4

Diagnostic Tools

  • Laser Doppler imaging (LDI) provides fast, noninvasive, and accurate delineation of areas of vascular occlusion and is more precise than visual inspection or photographic evidence, though not widely available 5
  • Clinical observation remains the primary diagnostic method in most settings 2, 5

Emergency Treatment Protocol

Immediate Actions (Within Minutes)

  • Stop injection immediately upon recognition of any signs of vascular compromise 2
  • Administer high-dose pulsed hyaluronidase protocol using 4 pulses of hyaluronidase injection in the first 24 hours after filler injection 4, 2
  • Inject hyaluronidase directly into and around the affected area, including along the suspected vascular distribution 4, 2
  • Apply topical nitropaste under occlusion to promote vasodilation 2
  • Administer oral acetylsalicylic acid (aspirin) to prevent thrombotic extension 2
  • Apply warm compresses to the affected area 2
  • Perform vigorous massage of the affected tissue 2

Secondary Treatment Lines

  • Intra-arterial hyaluronidase injection may be considered for severe cases 2
  • Hyperbaric oxygen therapy can be utilized as adjunctive treatment 2
  • Ancillary vasodilating agents such as prostaglandin E1 may be employed 2

Emergency Preparedness

  • Maintain a "filler crash cart" with immediate access to hyaluronidase, nitropaste, aspirin, and warm compresses, since early intervention significantly reduces morbidity 2
  • Complete resolution of cutaneous ischemic changes can be achieved within days after prompt treatment with the high-dose hyaluronidase protocol 4

Critical Pitfalls to Avoid

Technical Errors

  • Never inject deep into the hypodermis where the mental artery resides 1
  • Avoid injecting large boluses that can cause vascular compression even without direct intravascular injection 1, 2
  • Do not inject too superficially with long-lasting fillers, as this causes visible irregularities and increases complication risk 6

Recognition and Treatment Delays

  • The true incidence of vascular complications is unknown due to underreporting by clinicians, but early recognition and immediate treatment are critical to prevent tissue necrosis 2
  • Delayed treatment beyond the first 24 hours significantly worsens outcomes and increases the risk of permanent tissue loss 4, 2

Management Errors

  • Intralesional steroid injections and 5-fluorouracil are appropriate for late complications like granulomas and nodules, but are NOT indicated for acute vascular occlusion 6
  • Surgical excision should remain the last option for hard lumps and visible nodules, not for acute vascular emergencies 6

Alternative Considerations

  • Consider autologous platelet concentrates (APCs) instead of traditional hyaluronic acid fillers when volumization is not the primary goal, as APCs carry lower vascular risk and are particularly appropriate for fine lines and overall rejuvenation 1
  • APCs have effects lasting only 3-4 months versus longer-lasting traditional fillers, but may be safer in high-risk vascular areas 1

References

Guideline

Local Anesthetic Injection Techniques

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Avoiding and treating dermal filler complications.

Plastic and reconstructive surgery, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.